Skip to main content
Premium Trial:

Request an Annual Quote

Illumina, BioMérieux Collaborate on NGS-Based Applications for Microbiology

NEW YORK (GenomeWeb) – BioMérieux and Illumina today announced a collaboration to develop applications for microbiology sequencing technologies.

The work, to be conducted over a four-year renewable period, will combine Illumina's MiSeq next-generation sequencing system with a jointly developed pathogen genome database based on BioMérieux's culture collection containing more than 80,000 references.

The first application will be an NGS epidemiological solution to enable service labs to genotype disease agents. The application will provide "easily accessible and highly accurate information to communities and hospitals to track, prevent, contain, and stop the spread of disease agents" by delivering "a standardized report with a genomic profile of the infectious agent with sequence-level accuracy and depth of information," the partners said.

The goal of the collaboration is to arm public health and hospital microbiology labs with tools to contain an epidemic, avoid transmission of infectious agents, and improve hospital practices. Healthcare providers will be able to send the relevant isolates to a designated lab equipped with an Illumina platform. Genetic sequences will be sent securely through a cloud platform to be analyzed using the database and software developed by BioMérieux, and the lab will be able to generate a customized report for the customer.

Financial and other terms of the agreement were not disclosed.

"With this new collaboration, we will enrich our commercial offering by adding a sequencing solution dedicated to infectious diseases," BioMérieux Chairman Jean-Luc Belingard said in a statement. "Moreover, this collaboration is a first step that will enable BioMérieux to identify opportunities and fields of application that sequencing can bring to infectious disease diagnostics."

The Scan

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Targets Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.